CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

News Charles River Laboratories International, Inc. Berne S.E.

Stocks

RV6

US1598641074

Biotechnology & Medical Research

Delayed Berne S.E. Other stock markets			5-day change	1st Jan Change
- ^CHF	-.--%		-.--%	-

06-05	Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says	MT
06-03	Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 09:55 AM

All News

Mentions Relevance

06-05	Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says	MT
06-03	Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 09:55 AM
06-03	Charles River Laboratories International, Inc. Presents at 46th Annual William Blair Growth Stock Conference, Jun-02-2026 10:00 AM
06-01	Charles River Laboratories to Present at William Blair and Jefferies Conferences	BU
05-13	Charles River Laboratories, Medipost Sign MoU on GMP-Compliant Testing	MT
05-13	Charles River Laboratories and Medipost sign non-exclusive MoU to advance GMP testing solutions	RE
05-13	Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions	BU
05-12	Charles River Laboratories International, Inc. Approves Ratification of PricewaterhouseCoopers LLP as Independent Auditors	CI
05-12	Charles River Laboratories International, Inc. Announces Board Elections	CI
05-11	Charles River Laboratories International, Inc. Accelerates Digital Pathology with Ai-Powered End-To-End Workflow	CI
05-11	Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow	BU
05-08	Charles River Laboratories International, Inc. Seeks M&A Opportunities	CI
05-08	Charles River Laboratories International : Quarterly Report for Quarter Ending March 28, 2026 (Form 10-Q)	PU
05-08	Tranche Update on Charles River Laboratories International, Inc.'s Equity Buyback Plan announced on November 5, 2025.	CI
05-07	Charles River Laboratories International, Inc., Q1 2026 Earnings Call, May 07, 2026
05-07	Charles River Laboratories International, Inc. Reports Earnings Results for the First Quarter Ended March 28, 2026	CI
05-07	Charles River Laboratories Q1 Adjusted Earnings Decline, Revenue Rises; Maintains 2026 Earnings Guidance	MT
05-07	(CRL) Charles River Laboratories International Expects 2026 Non-GAAP EPS Range $10.80 - $11.30, vs. FactSet Est of $11.08	MT
05-07	Earnings Flash (CRL) Charles River Laboratories International, Inc. Posts Q1 Adjusted EPS $2.06 per Share, vs. FactSet Est of $1.94	MT
05-07	Charles River beats quarterly estimates on steady demand for drug development services	RE
05-07	Earnings Flash (CRL) Charles River Laboratories International, Inc. Reports Q1 Revenue $995.8M, vs. FactSet Est of $977.5M	MT
05-07	Earnings Flash (CRL) Charles River Laboratories International, Inc. Reports Q1 Revenue $995.8M, vs. FactSet Est of $977.5M	MT
05-07	Charles River Laboratories International : Q1 2026 Earnings Presentation	PU
05-07	Charles River: Q1 Earnings Snapshot	AQ
05-07	Charles River Laboratories Announces First-Quarter 2026 Results	BU